M. D. de Souza

Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase

Derek S. Tan, E. Winzeler, E. Istvan, 2023, Research Square.

Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics

Luma G. Magalhães, Leonardo L. G. Ferreira, Leonardo L G Ferreira, 2022, Frontiers in Pharmacology.

Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.

Leonardo L. G. Ferreira, R. S. Ferreira, G. Oliva, 2017, Future medicinal chemistry.

Discovery of Potent, Reversible and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.

Mariana L. de Souza, Celso de Oliveira Rezende Junior, Rafaela Salgado Ferreira, 2019, Journal of chemical information and modeling.

Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-Trypanosoma cruzi activity.

S. Michelan-Duarte, Ivani Pauli, M. Valli, 2024, Future medicinal chemistry.

Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors

Leonardo L. G. Ferreira, Leonardo L G Ferreira, A. Andricopulo, 2021, Biomolecules.

Structure-Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials.

J. Y. Roberge, P. Bhanot, John Gilleran, 2024, Journal of medicinal chemistry.

New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease

Gustavo Henrique Goulart Trossini, S. Murta/, D. Liarte, 2024, Expert opinion on drug discovery.